Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABEPSFF 42 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates EPSFF with a GF Score™ of 42/100 and a GF Value™ of $0.16. The stock has 7 warning signs investors should review. Among 280 Medical Devices & Instruments companies, Episurf Medical AB ranks worse than 357142.5% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Episurf Medical AB's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Episurf Medical AB's Dividend Payout Ratio or its related term are showing as below:
EPSFF's Dividend Payout Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.42 * Ranked among companies with meaningful Dividend Payout Ratio only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Episurf Medical AB (OTCPK:EPSFF) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Episurf Medical AB Dividend Payout Ratio Related Terms
Episurf Medical AB Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Episurf Medical AB's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPSFF vs ABT, SYK, MDT: Dividend Payout Ratio Comparison
For the Medical Devices subindustry, Episurf Medical AB's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB Dividend Payout Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's Dividend Payout Ratio falls into.
Episurf Medical AB Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Episurf Medical AB's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Episurf Medical AB (EPSFF) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Episurf Medical AB and its competitors. According to the industry distribution chart, Episurf Medical AB ranks #999999 out of 280 companies in the Medical Devices & Instruments industry.
Is Episurf Medical AB's Dividend Payout Ratio too high?
Episurf Medical AB's current Dividend Payout Ratio is 0.00. Based on the distribution chart, Episurf Medical AB ranks #999999 out of 280 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Episurf Medical AB has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Episurf Medical AB's Dividend Payout Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #999999 out of 280 companies for Dividend Payout Ratio. This places Episurf Medical AB in the lower half of its industry. The industry median Dividend Payout Ratio is 0.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Devices & Instruments company?
The median Dividend Payout Ratio among Medical Devices & Instruments companies is 0.42, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Episurf Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Dividend Payout Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Episurf Medical AB's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Episurf Medical AB (EPSFF) has a current Dividend Payout Ratio of 0.00. The stock's GF Value™ is $0.16, compared to a current price of $0.18 — trading 13.7% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Episurf Medical AB's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Episurf Medical AB (EPSFF), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Episurf Medical AB (EPSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Episurf Medical AB stock appears to be overvalued.
The current stock price of $0.18 is trading 13.7% above its estimated GF Value™ of $0.16.
Key valuation signals for EPSFF:
Dividend Payout Ratio: 0.00
GF Value™: $0.16 vs. price of $0.18 (13.7% above fair value)
No single metric tells the full story. See the EPSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
42GF Score
Get the complete analysis for EPSFF
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPSFF has been successfully added to your 
